Skip to main content

Table 3 Diagnostic indices of maternal PlGF, sFLT-1, and their ratio for identifying patients who will develop preeclampsia, hypertension without proteinuria, normotensive IUGR, and induced delivery at <34 weeks of gestation

From: Prediction of preeclampsia and induced delivery at <34 weeks gestation by sFLT-1 and PlGF in patients with abnormal midtrimester uterine Doppler velocimetry: a prospective cohort analysis

  

Chi-Square P-value

Sensitivity

Specificity

PPV

NPV

LR + (95% CI)

LR- (95% CI)

OR (95% CI)

PE (n = 12)

PlGF

0.027

58.3%

78.9%

46.7%

85.7%

2.77 (1.27-6.04)

0.53 (0.27-1.05)

5.25 (1.31-21.03)

 

sFLT-1

0.240

16.7%

94.7%

50.0%

78.3%

3.17 (0.50-20.13)

0.88 (0.68-1.15)

3.60 (0.45-28.86)

 

sFLT-1/PlGF ratio

<0.001

66.7%

89.5%

66.7%

89.5%

6.33 (2.31-17.38)

0.37 (0.17-0.84)

17.0 (3.50-83.02)

Gestational hypertension (n = 16)

PlGF

0.514

37.5%

73.5%

40.0%

71.4%

1.42 (0.61-3.30)

0.85 (0.55-1.31)

1.67 (0.47-5.92)

 

sFLT-1

1.000

6.3%

91.2%

25.0%

67.4%

0.71 (0.08-6.29)

1.03 (0.87-1.21)

0.69 (0.067-7.19)

 

sFLT-1/PlGF ratio

0.292

12.5%

70.6%

16.7%

63.2%

0.43 (0.11-1.72)

1.24 (0.93-1.65)

0.34 (0.07-1.79)

IUGR (n = 6)

PlGF

0.654

16.7%

68.2%

6.7%

85.7%

0.52 (0.08-3.30)

1.22 (0.81-1.84)

0.43 (0.05-4.02)

 

sFLT-1

1.000

0.0%

90.9%

0.0%

87.0%

0.00

1.10 (1.00-1.21)

0.00

 

sFLT-1/PlGF ratio

1.000

16.7%

75.0%

8.3%

86.8%

0.67 (0.10-4.29)

1.11 (0.75-1.65)

0.60 (0.06-5.71)

Induced delivery < 34 weeks (n = 7)

PlGF

0.176

57.1%

74.4%

26.7%

91.4%

2.23 (0.98-5.07)

0.58 (0.34-1.38)

3.88 (0.75-20.12)

 

sFLT-1

0.089

28.6%

95.4%

50.3%

89.1%

6.14 (1.03-36.79)

0.75 (0.47-1.20)

8.20 (0.94-71.73)

 

sFLT-1/PlGF ratio

<0.001

85.7%

86.1%

50.1%

97.4%

6.14 (2.76-13.69)

0.17 (0.03-1.02)

37.00 (3.76-363.91)

Early-onset PE (n = 9)

PlGF

0.220

50.0%

73.8%

26.7%

88.6%

1.91 (0.81-4.51)

0.68 (0.33-1.39)

2.82 (0.60-13.24)

 

sFLT-1

0.115

25.0%

95.2%

50.0%

87.0%

5.25 (0.86-32.02)

0.79 (0.53-1.18)

6.67 (0.79-56.64)

 

sFLT-1/PlGF ratio

0.001

75.0%

85.7%

50.0%

94.7%

5.25 (2.26-12.18)

0.29 (0.09-0.98)

18.00 (2.92-110.96)

Late-onset PE (n = 3)

PlGF

0.075

75.0%

73.9%

20.0%

97.1%

2.88 (1.36-6.06)

0.34 (0.06-1.86)

8.50 (0.81-89.75)

 

sFLT-1

1.000

0.0%

91.3%

0.0%

91.3%

0.00

1.10 (1.00-1.20)

0.00

 

sFLT-1/PlGF ratio

0.240

50.0%

78.3%

16.7%

94.7%

2.30 (0.75-7.07)

0.64 (0.24-1.72)

3.60 (0.46-28.86)

  1. Cut-off levels were defined as < 5th centile for PlGF and > 95th centile for sFLT-1 and the sFLT-1/PlGF ratio according to gestational specific reference values.
  2. PE = Preeclampsia, GH = Gestational hypertension, IUGR = Intrauterine growth restriction, PPV = Positive predictive value, NPV = Negative predictive value, OR = Odds ratio, LR+/- = positive/negative Likelihood ratio.